Shopping Cart 0
Cart Subtotal
USD 0

University of Texas Southwestern Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System is an educational center that offers medical research and education programs. The center offers degree programs, which include master's degree in business administration, public health, medical scientist training program and bachelor of arts in biology. It offers training programs in various fields. The center carries out research activities in the areas of oncology, diabetes, obesity, cardiology, metabolism and nutrition, trauma and others. It operates through its academic medical centers, patient care providers and research institutions. UTSMC is headquartered in Dallas, Texas, the US.

University of Texas Southwestern Medical Center-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 6

List of Figures 6

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

University of Texas Southwestern Medical Center, Medical Devices Deals, 2012 to YTD 2018 11

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deal Details 14

Partnerships 14

University of Texas Southwestern Medical Center Extends Licensing Agreement With DioGenix For MSPrecise Sequencing Assay 14

United Neuroscience Enters into Agreement with University of Texas Southwestern Medical Center 15

Curadev Pharma Enters into Research Partnership with University of Texas Southwestern Medical Center 16

Peloton Therapeutics Enters into Agreement with University of Texas Southwestern Medical Center 17

Immune-Onc Therapeutics Enters into Research Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 18

CureMeta Enters into Research Agreement with University of Texas Southwestern Medical Center 19

SignaBlok Enters into Agreement with University of Texas Southwestern Medical Center 20

Licensing Agreements 21

Pieces Tech Enters into Licensing Agreement with University of Texas Southwestern Medical Center 21

Immune-Onc Therapeutics Enters into Licensing Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 22

arGEN-X Enters into Licensing Agreement with University of Texas Southwestern Medical Center 23

Lonestar Heart Acquires Rights from University of Texas Southwestern Medical 24

arGEN-X Amends its Licensing Agreement with University of Texas Southwestern Medical Center for NHance Technology 25

LoneStar Heart Enters Into Licensing Agreement With UT Southwestern Medical Center For Isoxazoles 27

University Of Illinois And University Of Texas Enter Into Licensing Agreement With StemPar Sciences For Anti-Cancer Compounds 28

University of Texas Southwestern Medical Center-Key Competitors 29

University of Texas Southwestern Medical Center-Key Employees 30

University of Texas Southwestern Medical Center-Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Recent Developments 33

Corporate Communications 33

Feb 08, 2018: Warner Selected As EVP To Lead UT Southwestern Health System 33

Government and Public Interest 34

Sep 11, 2018: USD 37 million CPRIT support includes funds for pediatric cancer database 34

Sep 04, 2018: Know the symptoms of AFib to prevent stroke and heart failure 36

Aug 30, 2018: CRISPR halts Duchenne muscular dystrophy progression in dogs 37

Aug 24, 2018: CPRIT Surpasses USD 2 Billion Milestone with 64 New Grants 39

Aug 21, 2018: Patients with rare brain diseases help scientists open new doors for gene therapy 45

Aug 01, 2018: UTSW scientists identify new mechanisms underlying pediatric kidney cancer 49

Jul 10, 2018: The 'Big Bang' of Alzheimer's Scientists ID genesis of disease, focus efforts on deadly shape-shifting tau protein 51

Jul 05, 2018: UTSW scientists identify body's microreactors for innate immunity 53

Jun 28, 2018: Researchers discover new vulnerability in deadly form of lung cancer 54

Jun 05, 2018: Zebrafish expose tumor pathway in childhood muscle cancer 55

May 10, 2018: New Grants Totaling USD 2.6 Million Fund Work to Reduce Immunotherapy Side Effects 56

May 08, 2018: Kathryne and Gene Bishop commit more than USD 6 million To find breakthroughs in pediatric medicine 57

May 04, 2018: UTSW investigation provides insight into potential new strategy to target skin diseases like psoriasis 58

May 02, 2018: Cryo-EM structures of the nicotine receptor may lead to new therapies for nicotine addiction 59

Apr 19, 2018: Scientists identify 170 potential lung cancer drug targets using unique cellular library 60

Apr 18, 2018: Researchers identified a protein associated with breast cancer 62

Mar 29, 2018: CPRIT awards UT Southwestern investigators USD 27 million for cancer prevention and research 63

Mar 29, 2018: Anti-aging protein alpha Klotho's molecular structure revealed 65

Mar 28, 2018: UTSW study helps explain launch switch for most common malignant pediatric brain tumor 67

Mar 27, 2018: Gene therapy may help brain heal from stroke, other injuries 68

Mar 21, 2018: Targeting Telomeres to Overcome Therapy Resistance in Advanced Melanoma 69

Feb 12, 2018: CRISPR method efficiently corrects DMD defect in heart tissue 70

Feb 06, 2018: New CRISPR method efficiently corrects DMD defect in heart tissue 71

Feb 01, 2018: Simmons Cancer Center researchers part of historic CAR-T breakthrough 73

Jan 03, 2018: Precision editing of gut bacteria: Potential way to treat colitis 74

Dec 20, 2017: FDA-approved high blood pressure drug extends life span in roundworms 76

Dec 11, 2017: Magnetic fields turn up the heat on bacterial biofilms 77

Dec 05, 2017: UTSW Researchers Identify Possible New Way to Treat Parasitic Infections 79

Nov 29, 2017: Researchers devise improved gene-editing process for Duchenne muscular dystrophy 81

Nov 22, 2017: University of Texas Southwestern Medical Center: More not necessarily better with heart valve operations 83

Nov 13, 2017: O'Donnell Brain Institute joins global effort to map human cells 84

Nov 07, 2017: Hamon Charitable Foundation USD 10M gift fuels Alzheimer's research 85

Nov 01, 2017: Study: Autism Treatments May Restore Brain Connections 86

Oct 03, 2017: Genetic Targets to Chemo-Resistant Breast Cancer Identified 87

Sep 19, 2017: CPRIT awards USD 34M to UTSW for cancer research recruitment 88

Aug 24, 2017: CRI scientists develop an innovative system to characterize regulatory DNA sequences responsible for human diseases 90

Aug 23, 2017: DNA sensor plays critical role in cancer immunotherapy via robust response to unexpected form of DNA 91

Aug 21, 2017: CRI scientists discover vitamin C regulates stem cell function and suppresses leukemia development 93

Aug 08, 2017: First-in-class drug holds promise for therapy-resistant breast cancer 95

Jul 27, 2017: UT Southwestern researchers find link between backup immune defense, mutation seen in Crohn's disease 96

Jul 21, 2017: CRI Scientists Increase our Understanding of the Genetic Basis of Neuropsychiatric Disorders 98

Jul 07, 2017: Researchers report chemical reaction with potential to speed drug development 99

Jun 13, 2017: Researchers identify best treatment for iron deficiency anemia in children 100

Jun 12, 2017: Study: New approach to destroying deadly brain tumors 101

Jun 12, 2017: Beat AML clinical trial for leukemia is launched 103

May 23, 2017: Using a genetic signature to overcome chemotherapy-resistant lung cancer 105

May 22, 2017: DNA vaccine protects against toxic proteins linked to Alzheimer's 107

May 09, 2017: Research elucidates hormone ghrelin's role in blood glucose regulation, a finding with promising implications for diabetes treatment 109

May 01, 2017: Stereotactic radiation highly effective for kidney cancer 110

Apr 12, 2017: Gene-editing alternative corrects Duchenne muscular dystrophy 111

Feb 06, 2017: Researchers identify ion channel necessary for hormone and anti-obesity drug to suppress eating 112

Jan 24, 2017: Researchers discover BRCA1 gene is key for blood forming stem cells 113

Jan 24, 2017: Researchers discover potential new target for treating glioblastoma 114

Jan 11, 2017: Scientists identify protein central to immune response against tuberculosis bacteria 116

Product News 117

08/30/2017: UT Health San Antonio researchers developing drug for recurring ER-positive breast cancer 117

Jun 19, 2018: Decades of dedication lead to drug trial for rare, fatal illness 118

Apr 24, 2017: Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types 121

Feb 06, 2017: UTSW identifies ion channel necessary for hormone and anti-obesity drug to suppress eating 123

02/03/2017: Cancer drug could promote regeneration of heart tissue 124

Jan 03, 2017: Researchers uncover mechanism for cancer-killing properties of pepper plant 125

Jan 02, 2018: State-of-the-art MRI technology bypasses need for biopsy 126

Other Significant Developments 127

Aug 30, 2018: Blocking cellular pathway may make radiotherapy more effective by activating immune system, early study reports 127

Jul 26, 2018: Desperately ill patients will get better access to experimental treatments through new effort 128

Appendix 130

Methodology 130

About GlobalData 130

Contact Us 130

Disclaimer 130


List Of Figure

List of Figures

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

University of Texas Southwestern Medical Center, Medical Devices Deals, 2012 to YTD 2018 11


List Of Table

List of Tables

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Key Facts 2

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

University of Texas Southwestern Medical Center, Deals By Therapy Area, 2012 to YTD 2018 10

University of Texas Southwestern Medical Center, Medical Devices Deals, 2012 to YTD 2018 11

University of Texas Southwestern Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

University of Texas Southwestern Medical Center Extends Licensing Agreement With DioGenix For MSPrecise Sequencing Assay 14

United Neuroscience Enters into Agreement with University of Texas Southwestern Medical Center 15

Curadev Pharma Enters into Research Partnership with University of Texas Southwestern Medical Center 16

Peloton Therapeutics Enters into Agreement with University of Texas Southwestern Medical Center 17

Immune-Onc Therapeutics Enters into Research Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 18

CureMeta Enters into Research Agreement with University of Texas Southwestern Medical Center 19

SignaBlok Enters into Agreement with University of Texas Southwestern Medical Center 20

Pieces Tech Enters into Licensing Agreement with University of Texas Southwestern Medical Center 21

Immune-Onc Therapeutics Enters into Licensing Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 22

arGEN-X Enters into Licensing Agreement with University of Texas Southwestern Medical Center 23

Lonestar Heart Acquires Rights from University of Texas Southwestern Medical 24

arGEN-X Amends its Licensing Agreement with University of Texas Southwestern Medical Center for NHance Technology 25

LoneStar Heart Enters Into Licensing Agreement With UT Southwestern Medical Center For Isoxazoles 27

University Of Illinois And University Of Texas Enter Into Licensing Agreement With StemPar Sciences For Anti-Cancer Compounds 28

University of Texas Southwestern Medical Center, Key Competitors 29

University of Texas Southwestern Medical Center, Key Employees 30

University of Texas Southwestern Medical Center, Other Locations 32

University of Texas Southwestern Medical Center, Subsidiaries 32

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Texas Southwestern Medical Center, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.